MOESM2 of Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial

Autor: Kondo, Yaeko, Harada, Norio, Hamasaki, Akihiro, Kaneko, Shizuka, Yasuda, Koichiro, Ogawa, Eiichi, Shin-Ichi Harashima, Yoneda, Hiroko, Fujita, Yoshihito, Norikazu Kitano, Nakamura, Yoshio, Matsuo, Fujio, Shinji, Megumi, Hinotsu, Shiro, Nakayama, Takeo, Nobuya Inagaki
Rok vydání: 2016
DOI: 10.6084/m9.figshare.c.3598196_d2
Popis: Additional file 2: Figure S2. Time course of HbA1c from baseline to 52Â weeks in the FAS. White circles with a dotted line: glimepiride group, filled black circles with a solid line: sitagliptin group. Values show least-squares mean with 95Â % confidence interval (CI) estimated by a mixed-model for repeated measures analysis, including terms for baseline HbA1c visit and treatment by visit interaction. There was no significant difference between the two groups at any point.
Databáze: OpenAIRE